Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02449499 · ClinicalTrials.gov registry record
Adjunct Interpersonally Focused Psychodynamic Group Psychotherapy for Residual Depression Symptoms
A clinical trial, sponsored by Stanford University.
- Terminated
- Registry status
- 25
- Enrollment target
NCT02449499: Clinical Trial study, sponsored by Stanford University.
NCT02449499 is a clinical trial that was terminated before completion, run by Stanford University. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02449499 was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- 25 participants
- Enrollment target
Study Summary
Depression and anxiety disorders, even when treated according to standard of care consisting of individual treatment with medication and/or therapy, can be associated with significant residual impact on quality of life. The purpose of this research is carry out an observational study of an existing clinical treatment, adjunctive interpersonally focused psychodynamic group therapy, to determine if this can improve quality of life for patients who have residual symptoms of chronic depression and anxiety.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2015-04 |
| Est. Completion | 2016-10 |
Why NCT02449499 stopped before completion
NCT02449499 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02449499 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02449499 about?
NCT02449499 is a clinical study titled "Adjunct Interpersonally Focused Psychodynamic Group Psychotherapy for Residual Depression Symptoms". Depression and anxiety disorders, even when treated according to standard of care consisting of individual treatment with medication and/or therapy, can be associated with significant residual impact on quality of life. The purpose of this research is carry out an observational study of an existing ...
What is the current status of trial NCT02449499?
This trial is currently terminated. The enrollment target is 25 participants. The study started on 2015-04. Estimated completion is 2016-10.
Who is sponsoring clinical trial NCT02449499?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia